Skip to content
Screener

MiMedx Group MDXG Q1 2026 earnings

Reported April 29, 2026 · After market close

Revenue$59.0MMiss by $6.8M
EPS-$0.05Beat by $0.02
Revenue estimate$65.8M
EPS estimate-$0.07

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$69.6M
EPS estimate$0.01

Financials

Q1 2026

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$586.84M-47.6%
Enterprise value$444.66M-56.9%
P/E19.1×-8.8×
P/S1.5×-1.7×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Segments

By product

See full
Surgical$36.4M+13.2%
Wound$22.6M-59.7%

FAQ

When did MiMedx Group report Q1 2026 earnings?
MiMedx Group (MDXG) reported Q1 2026 earnings on April 29, 2026 after market close.
What were MiMedx Group's Q1 2026 revenue and EPS?
MiMedx Group reported revenue of $59.0M and eps of $-0.05 for Q1 2026.
Did MiMedx Group beat estimates in Q1 2026?
Revenue missed the consensus estimate of $65.8M by $6.8M. EPS beat the consensus estimate of $-0.07 by $0.02.
How did MiMedx Group's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 33.1% from $88.2M a year earlier.
Where can I find MiMedx Group's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001376339-26-000032) and the 10-Q periodic report (0001376339-26-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.